Skip to content

Mahmoud Eljalby

NPI 1245816065ActiveIndividual· Internal Medicine· Saint Louis, MO

Internal Medicine in Saint Louis, Missouri, licensed in MO, with an NPI issued in March 2021. Part D covered 220 prescriptions written in 2024, 83% of them generic. Abbott Laboratories was the largest of 2 companies reporting payments in 2024, $279.64 in all, mostly education.

Overview

NPI1245816065
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMar 22, 2021
Last updated in NPPESNov 25, 2024
Certified by providerNov 25, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X2024046599MO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Cardiovascular Disease (Cardiology) (MO)

Part D prescriptions in 2024

Prescriptions (claims)220 · 410 30-day fills
Patients25
Total drug cost$19,354
Generic share83% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$279.64 · 3 payments from 2 companies

Top paying companies in 2024

CompanyAmountPayments
Abbott Laboratories$237.172
Abiomed$42.471

What the 2024 payments were for

  • Education$237.17 · 2 payments
  • Food and Beverage$42.47 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Saint Louis

All 1,093 internal medicine physicians in Saint Louis · All internal medicine physicians in Missouri